Literature DB >> 29517504

Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers.

Yun Sol Jo1, Min Sung Kim, Nam Jin Yoo, Sug Hyung Lee.   

Abstract

MYH11 functions as a contractile protein, converting chemical energy into mechanical energy through adenosine triphosphate hydrolysis. In cancers, an oncogenic fusion CBFB/MYH11 and frameshift mutations have been reported. Truncating mutants of MYH11 exhibited increased ATPase and motor activity, suggesting their roles in energy balance and movement of cancer cells. MYH11 gene has a mononucleotide repeat (C8) in the coding sequences that could be a mutational target in the cancers exhibiting microsatellite instability (MSI). We analyzed the C8 repeat in 79 gastric cancers (GCs) and 124 colorectal cancers (CRCs) including 113 high MSI (MSI-H) and 90 microsatellite stable/low MSI cases. We detected MYH11 frameshift mutations in 4 (11.8%) GCs and 17 (21.5%) CRCs with MSI-H (21/113, 18.6%), but not in microsatellite stable/low MSI cancers (0/90) (P<0.001). We also analyzed intratumoral heterogeneity (ITH) of the MYH11 frameshift mutations and found that 10 of 16 CRCs (62.5%) harbored the regional ITH. Our results show that MYH11 gene harbors somatic frameshift mutations mostly associated with mutational ITH, which together may be features of MSI-H GCs and CRCs. Practically, the data suggest that multiregional analysis is needed for a better evaluation of mutation status in MSI-H tumors to overcome ITH.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29517504     DOI: 10.1097/PAI.0000000000000484

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  5 in total

1.  LncRNA Sox2ot modulates the progression of thoracic aortic aneurysm by regulating miR-330-5p/Myh11.

Authors:  Weizhang Xiao; Xing Li; Cheng Ji; Jiahai Shi; Youmin Pan
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

2.  Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention.

Authors:  Gloria Pelizzo; Luigi Chiricosta; Emanuela Mazzon; Gian Vincenzo Zuccotti; Maria Antonietta Avanzini; Stefania Croce; Mario Lima; Placido Bramanti; Valeria Calcaterra
Journal:  Pediatr Rep       Date:  2021-01-05

3.  Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer.

Authors:  Yucheng Qian; Jingsun Wei; Wei Lu; Fangfang Sun; Maxwell Hwang; Kai Jiang; Dongliang Fu; Xinyi Zhou; Xiangxing Kong; Yingshuang Zhu; Qian Xiao; Yeting Hu; Kefeng Ding
Journal:  Front Genet       Date:  2021-03-04       Impact factor: 4.599

4.  A Non-canonical Wnt Signature Correlates With Lower Survival in Gastric Cancer.

Authors:  Pablo Astudillo
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 5.  Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer.

Authors:  Nayden G Naydenov; Susana Lechuga; Emina H Huang; Andrei I Ivanov
Journal:  Cancers (Basel)       Date:  2021-02-11       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.